- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
Roivant Sciences Funding
$1.9B
44 rounds
Roivant Sciences is active in the following markets / industries: health care, pharmaceuticals and bio pharm. The company has secured funding across 4 rounds, totaling in an amount of $1.9B. Their most recent funding was raised on November 13, 2018.
Funding Rounds
U
$200000000U
$1100000000U
$500000000U
$93000000Investors of Roivant Sciences
SoftBank Vision Fund
Invests in AI and tech companies to build market-leading businesses
Rounds
U
Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
U
